NRXPNRx Pharmaceuticals, Inc.Mar 24, 2026Q4 2025
Read transcript →NRx Pharmaceuticals, Inc. (NRXP) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.96
-2.31%
Mkt Cap $52.38M
NRXPNRx Pharmaceuticals, Inc.Mar 24, 2026NRXPNRx Pharmaceuticals, Inc.Nov 17, 2025Q3 2025
Read transcript →NRXPNRx Pharmaceuticals, Inc.Aug 20, 2025Q2 2025
Read transcript →NRXPNRx Pharmaceuticals, Inc.May 16, 2025Q1 2025
Read transcript →NRXPNRx Pharmaceuticals, Inc.Mar 17, 2025Q4 2024
Read transcript →NRXPNRx Pharmaceuticals, Inc.Nov 18, 2024Q3 2024
Read transcript →NRXPNRx Pharmaceuticals, Inc.Aug 15, 2024Q2 2024
Read transcript →NRXPNRx Pharmaceuticals, Inc.May 14, 2024Q1 2024
Read transcript →NRXPNRx Pharmaceuticals, Inc.Apr 1, 2024Q4 2023
Read transcript →NRXPNRx Pharmaceuticals, Inc.Nov 14, 2023Q3 2023
Read transcript →NRXPNRx Pharmaceuticals, Inc.Aug 14, 2023Q2 2023
Read transcript →NRXPNRx Pharmaceuticals, Inc.May 16, 2023Q1 2023
Read transcript →NRXPNRx Pharmaceuticals, Inc.Mar 30, 2023Q4 2022
Read transcript →NRXPNRx Pharmaceuticals, Inc.Nov 14, 2022Q3 2022
Read transcript →NRXPNRx Pharmaceuticals, Inc.Aug 15, 2022Q2 2022
Read transcript →NRXPNRx Pharmaceuticals, Inc.May 16, 2022Q1 2022
Read transcript →NRXPNRx Pharmaceuticals, Inc.Mar 31, 2022Q4 2021
Read transcript →NRXPNRx Pharmaceuticals, Inc.Nov 16, 2021Q3 2021
Read transcript →NRXPNRx Pharmaceuticals, Inc.Aug 17, 2021Q2 2021
Read transcript →